Recombinant Human Polyclonal Antibodies: A New Class of Therapeutic Antibodies Against Viral Infections

E-ISSN： 1873-4286|12|16|2007-2015

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.16, 2006-06, pp. : 2007-2015

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypersensitivity Reactions to Last Generation Chimeric, Umanized and Human Recombinant Monoclonal Antibodies for Therapeutic Use

Current Pharmaceutical Design, Vol. 14, Iss. 27, 2008-09 ,pp. : 2883-2891

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Antibodies

Drug Design Reviews - Online, Vol. 2, Iss. 3, 2005-05 ,pp. : 209-217

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of monoclonal antibodies (mAb) against native and recombinant human mannose-binding lectin (MBL)

By Zhao H. Stahl G.L.

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

Monoclonal antibodies for viral infections: where to, and how?

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Agonistic antibodies to human glucocorticoid-induced tumor necrosis factor receptor as potential stimulators of T cell immunity for the treatment of cancer and viral infections

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 567-575

Informa Healthcare

Access to resources Recommend Favorite